Aparito works with biotech, pharmaceutical, contract research organisations and academic institutions to provide better patient experiences of clinical trials in conjunction with patient advocacy groups.
Our regulatory expertise and patient advocacy work enable us to understand the needs of all stakeholders as we work with global multinational businesses to deliver clinical and registry studies to 8,000 patients in more than 20 countries in 18 different languages.
Aparito understands the needs of biotechs and has the expertise to develop novel strategies including world-leading digital endpoints and help minimise the financial risk involved in biotech drug development
Aparito understands the needs of pharma businesses and has the expertise to develop novel endpoints and incorporate RWE to help reduce time to market in pharmaceutical drug development
Aparito can help bridge the gap between sponsors, CROs and patients through our regulatory experience and our work with patient advocacy groups to design novel digital endpoints
Aparito’s work alongside academic partners helps drive healthcare change, improve service delivery to enhance the patient experience within clinical trials, and remain at the forefront of healthcare innovation.